Anavex Life Sciences (AVXL) EBITDA (2004 - 2025)
Anavex Life Sciences (AVXL) EBITDA from Sep 30, 2004 to Dec 31, 2025. The TTM Anavex Life Sciences (AVXL) EBITDA is -$40M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Anavex Life Sciences (AVXL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.11% |
| 3 Years TTM | -7.27% |
| 5 Years TTM | +7.70% |
| 10 Years TTM | +10.13% |
| All Time TTM | +35.12% |
Annual EBITDA change of Anavex Life Sciences (AVXL)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$46M | +7.86% |
| 2024 | -$43M | -9.47% |
| 2023 | -$48M | -1.00% |
| 2022 | -$48M | +26.56% |
| 2021 | -$38M | +44.25% |
| 2020 | -$26M | -0.04% |
| 2019 | -$26M | +52.41% |
| 2018 | -$17M | +28.16% |
| 2017 | -$13M | -8.68% |
| 2016 | -$15M | +22.43% |
| 2015 | -$12M | +305.39% |
| 2014 | -$2.97M | +38.79% |
| 2013 | -$2.14M | -50.46% |
| 2012 | -$4.32M | -30.10% |
| 2011 | -$6.18M | +9.38% |
| 2010 | -$5.65M | +2.73% |
| 2009 | -$5.50M | +2.80% |
| 2008 | -$5.35M | +238.61% |
| 2007 | -$1.58M | +5166.67% |
| 2006 | -$30K | -66.67% |
| 2005 | -$90K | +800.00% |
| 2004 | -$10K | N/A |
Comparison Anavex Life Sciences (AVXL) five years EBITDA CAGR with competitors
Anavex Life Sciences (AVXL) five years EBITDA CAGR is 7.71%.